This is a routine administrative filing for a securities quotation application on the ASX. No material news or financial data is provided. Monitor for future announcements regarding the outcome of the quotation application or any clinical pipeline updates.
Price Chart
Executive Summary
Alterity Therapeutics filed a Form 6-K with an exhibit (Exhibit 99.1) titled 'Application for quotation of securities - ATH', indicating a request to list additional securities on the Australian Securities Exchange (ASX). The filing is a routine administrative step for a development-stage biotech company and contains no financial data, clinical updates, or material business developments.
Key Facts
- Filed Form 6-K on August 3, 2026, for the month of August 2026.
- Exhibit 99.1 is titled 'Application for quotation of securities - ATH'.
- The company is described as 'a development stage enterprise'.
- The filing is incorporated by reference into existing S-8 and F-3 registration statements.
- No financial results, clinical data, or material agreements were disclosed.
Financial Impact
No financial impact disclosed in the filing.
Risk Factors
- No material risks disclosed in this filing; the company is a development-stage enterprise with no revenue.
- Potential dilution risk if the securities quotation application is for new shares, but no details are provided.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-025500 |
| Document: 0001437749-26-025500-index-headers.html | 0001437749-26-025500 |
| Document: 0001437749-26-025500-index.html | 0001437749-26-025500 |
| Document: 0001437749-26-025500.txt | 0001437749-26-025500 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.14 (−2.39%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.14 (+2.39%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.14 (+2.39%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.14 (−10.46%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.14 (−10.46%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.14 (−11.93%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.14 (−31.41%) |
Oct 5, 2026 22d ago | Press Release | $3.22 | awaiting T+60 | — | $2.14 (−33.54%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.14 (−33.54%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.14 (−41.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers